JMJD1C forms condensate to facilitate a RUNX1-dependent gene expression program shared by multiple types of AML cells
Protein & Cell · 2025
DOI: 10.1093/procel/pwae059 ↗Kurz gefasst
Fachartikel in der Zeitschrift Protein & Cell, 2025. Verfasst von Qian Chen und 14 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Molecular Oncology, School of Basic Medical Sciences, Tsinghua University, Beijing 100084, China. Hauptthemen laut MEDLINE: Core Binding Factor Alpha 2 Subunit, Leukemia, Myeloid, Acute, Jumonji Domain-Containing Histone Demethylases, Gene Expression Regulation, Leukemic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, NCI NIH HHS, Leukemia and Lymphoma Society.
Abstract (Originalsprache)
JMJD1C (Jumonji Domain Containing 1C), a member of the lysine demethylase 3 (KDM3) family, is universally required for the survival of several types of acute myeloid leukemia (AML) cells with different genetic mutations, representing a therapeutic opportunity with broad application. Yet how JMJD1C regulates the leukemic programs of various AML cells is largely unexplored. Here we show that JMJD1C interacts with the master hematopoietic transcription factor RUNX1, which thereby recruits JMJD1C to the genome to facilitate a RUNX1-driven transcriptional program that supports leukemic cell survival. The underlying mechanism hinges on the long N-terminal disordered region of JMJD1C, which harbors two inseparable abilities: condensate formation and direct interaction with RUNX1. This dual capability of JMJD1C may influence enhancer-promoter contacts crucial for the expression of key leukemic genes regulated by RUNX1. Our findings demonstrate a previously unappreciated role for the non-catalytic function of JMJD1C in transcriptional regulation, underlying a mechanism shared by different types of leukemias.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Molecular Oncology, School of Basic Medical Sciences, Tsinghua University, Beijing 100084, China.
- School of Life Sciences, Tsinghua-Peking Center for Life Sciences, Center for Synthetic and Systems Biology, Tsinghua University, Beijing 100084, China.
- School of Basic Medical Sciences, Tsinghua University, Beijing 100084, China.
- Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, United States.
- Nuclear Radiation Injury Protection and Treatment Department, Navy Medical Center of People Liberation Army (PLA), Second Military Medical University (Naval Medical University), Shanghai 200052, China.
- State Key Laboratory of Molecular Oncology, Tsinghua-Peking Center for Life Sciences, School of Basic Medical Sciences, Tsinghua University, Beijing 100084, China.
ORCID-Profile: Qian Chen, Pilong Li, Robert G Roeder, Mo Chen
Förderung
- National Key R&D Program of China
- NCI NIH HHS
- Leukemia and Lymphoma Society
- Beijing Municipal Natural Science Foundation
- Natural Science Foundation of China
Zitieren
APA
Chen, Q., Wang, S., Zhang, J., Xie, M., Lu, B., He, J., Zhen, Z., Li, J., Zhu, J., Li, R., Li, P., Wang, H., Vakoc, C. R., Roeder, R. G., & Chen, M. (2025). JMJD1C forms condensate to facilitate a RUNX1-dependent gene expression program shared by multiple types of AML cells. Protein & Cell. https://doi.org/10.1093/procel/pwae059
Vancouver
Chen Q, Wang S, Zhang J, Xie M, Lu B, He J, et al. JMJD1C forms condensate to facilitate a RUNX1-dependent gene expression program shared by multiple types of AML cells. Protein & Cell. 2025. doi:10.1093/procel/pwae059
BibTeX
@article{Chen2025,
author = {Chen, Qian and Wang, Saisai and Zhang, Juqing and Xie, Min and Lu, Bin and He, Jie and Zhen, Zhuoran and Li, Jing and Zhu, Jiajun and Li, Rong and Li, Pilong and Wang, Haifeng and Vakoc, Christopher R and Roeder, Robert G and Chen, Mo},
title = {JMJD1C forms condensate to facilitate a RUNX1-dependent gene expression program shared by multiple types of AML cells},
journal = {Protein & Cell},
year = {2025},
doi = {10.1093/procel/pwae059}
}
EUVIMED